Convalescent Plasma as Adjunct Therapy for COVID-19

NCT04873414 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
364
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

Collaborators